W Jing, T Xu, L Wu, PB Lopez,
C Grassberger… - JTO Clinical and …, 2022 - Elsevier
Introduction Durvalumab after concurrent chemoradiation (CCRT) for NSCLC improves
survival, but only in a subset of patients. We investigated the effect of severe radiation …